Home > Healthcare > ePrescribing Market > Table of Contents

ePrescribing Market – By Product (Solutions {Integrated, Standalone}, Services), Delivery Mode (Web/Cloud-based, On-premises), Substances (Controlled, Non-controlled), Usage (Handheld, Computer-based), Specialties, End-use, Global Forecast (2024 – 2032)

  • Report ID: GMI8999
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1   Market scope & definitions

1.2   Research design

1.2.1   Research approach

1.2.2   Data collection methods

1.3   Base estimates & calculations

1.3.1   Base year calculation

1.3.2   Key trends for market estimation

1.4   Forecast model

1.5   Primary research and validation

1.5.1   Primary sources

1.5.2   Data mining sources

Chapter 2   Executive Summary

2.1   Industry 360° synopsis

Chapter 3   Industry Insights

3.1   Industry ecosystem analysis

3.2   Industry impact forces

3.2.1   Growth drivers

3.2.1.1   Growing adoption of electronic health records (EHR)

3.2.1.2   Favorable government policies and funding

3.2.1.3   Increasing expenditure on healthcare

3.2.2   Industry pitfalls & challenges

3.2.2.1   Concern regarding security

3.3   Growth potential analysis

3.4   Regulatory landscape

3.5   Porter's analysis

3.6   PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1   Introduction

4.2   Company matrix analysis

4.3   Competitive analysis of major market players

4.4   Competitive positioning matrix

4.5   Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Million)

5.1   Key trends

5.2   Solutions

5.2.1   Integrated solutions

5.2.2   Standalone solutions

5.3   Services

5.3.1   Support

5.3.2   Implementation

5.3.3   Training

5.3.4   Network

Chapter 6   Market Estimates and Forecast, By Delivery Mode, 2021 – 2032 ($ Million)

6.1   Key trends

6.2   Web/cloud-based

6.3   On-premises

Chapter 7   Market Estimates and Forecast, By Substances, 2021 – 2032 ($ Million)

7.1   Key trends

7.2   Controlled substances

7.3   Non-controlled substances

Chapter 8   Market Estimates and Forecast, By Usage, 2021 – 2032 ($ Million)

8.1   Key trends

8.2   Handheld

8.3   Computer-based devices

Chapter 9   Market Estimates and Forecast, By Specialties, 2021 – 2032 ($ Million)

9.1   Key trends

9.2   Oncology

9.3   Sports medicine

9.4   Neurology

9.5   Cardiology

9.6   Other specialties

Chapter 10   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Million)

10.1   Key trends

10.2   Hospital

10.3   Office-based physicians

10.4   Pharmacy

10.5   Other end-users

Chapter 11   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

11.1   Key trends

11.2   North America

11.2.1    U.S.

11.2.2    Canada

11.3   Europe

11.3.1    Germany

11.3.2    UK

11.3.3    France

11.3.4    Spain

11.3.5    Italy

11.3.6    Rest of Europe

11.4   Asia Pacific

11.4.1    Japan

11.4.2    China

11.4.3    India

11.4.4    Australia

11.4.5    Rest of Asia Pacific

11.5   Latin America

11.5.1    Brazil

11.5.2    Mexico

11.5.3    Rest of Latin America

11.6   Middle East and Africa

11.6.1    South Africa

11.6.2    Saudi Arabia

11.6.3    Rest of Middle East and Africa

Chapter 12   Company Profiles

12.1    Allscripts Healthcare, LLC

12.2    Athenahealth

12.3    Change Healthcare

12.4    DrFirst

12.5    Epic Systems Corporation

12.6    McKesson Corporation

12.7    Networking Technology, Inc.

12.8    NXGN Management, LLC

12.9    Practice Fusion, Inc.

12.10    Surescripts

  

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 216
  • Countries covered: 19
  • Pages: 140
 Download Free Sample